CLOUGH CAPITAL PARTNERS L P - Q1 2015 holdings

$3.02 Billion is the total value of CLOUGH CAPITAL PARTNERS L P's 212 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 100.0% .

 Value Shares↓ Weighting
AUOTY ExitAU OPTRONICS CORPsponsored adr$0-10,000
-100.0%
-0.00%
GGN ExitGAMCO GLOBAL GOLD NAT RES &$0-13,800
-100.0%
-0.00%
ARMF ExitARES MULTI STRATEGY CR FD IN$0-11,700
-100.0%
-0.01%
GHY ExitPRUDENTIAL GLB SHT DUR HG YL$0-14,600
-100.0%
-0.01%
WIT ExitWIPRO LTDspon adr 1 sh$0-24,800
-100.0%
-0.01%
EWH ExitISHARESmsci hong kg etf$0-13,600
-100.0%
-0.01%
CLM ExitCORNERSTONE STRATEGIC VALUE$0-13,650
-100.0%
-0.01%
DVN ExitDEVON ENERGY CORP NEW$0-7,400
-100.0%
-0.02%
JMLP ExitNUVEEN ALL CAP ENE MLP OPPO$0-31,800
-100.0%
-0.02%
DSE ExitDUFF & PHELPS SLCT ENGY MLP$0-32,900
-100.0%
-0.02%
RSX ExitMARKET VECTORS ETF TRrussia etf$0-39,000
-100.0%
-0.02%
AAXJ ExitISHARESmsci ac asia etf$0-10,300
-100.0%
-0.02%
FOX ExitTWENTY FIRST CENTY FOX INCcl b$0-42,125
-100.0%
-0.06%
EARS ExitAURIS MED HLDG AG$0-428,682
-100.0%
-0.06%
GXC ExitSPDR INDEX SHS FDSs&p china etf$0-21,216
-100.0%
-0.06%
LBRKR ExitLIBERTY BROADBAND CORPright 01/09/2015$0-213,427
-100.0%
-0.07%
SLXP ExitSALIX PHARMACEUTICALS INC$0-47,900
-100.0%
-0.20%
AZN ExitASTRAZENECA PLCcall$0-97,700
-100.0%
-0.25%
TDG ExitTRANSDIGM GROUP INC$0-35,360
-100.0%
-0.25%
GNW ExitGENWORTH FINL INC$0-949,579
-100.0%
-0.29%
AAPL ExitAPPLE INC$0-86,700
-100.0%
-0.34%
BRCM ExitBROADCOM CORPcl a$0-251,000
-100.0%
-0.39%
RFMD ExitRF MICRODEVICES INC$0-763,935
-100.0%
-0.45%
HIG ExitHARTFORD FINL SVCS GROUP INC$0-335,533
-100.0%
-0.50%
WDC ExitWESTERN DIGITAL CORP$0-141,700
-100.0%
-0.56%
PFE ExitPFIZER INC$0-536,500
-100.0%
-0.60%
CODE ExitSPANSION INC$0-554,100
-100.0%
-0.68%
PCLN ExitPRICELINE GRP INC$0-16,624
-100.0%
-0.68%
KMX ExitCARMAX INC$0-308,600
-100.0%
-0.74%
ROP ExitROPER INDS INC NEW$0-143,500
-100.0%
-0.80%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Charles I. Clough, Jr. #1
  • James E. Canty #2
  • Eric A. Brock #3
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BK OF AMERICA CORP37Q3 20235.0%
MICROSOFT CORP35Q3 20235.5%
CITIGROUP INC33Q2 20215.8%
JPMORGAN CHASE & CO33Q3 20233.2%
D R HORTON INC32Q3 20233.2%
TRANSDIGM GROUP INC32Q3 20233.9%
VERTEX PHARMACEUTICALS INC32Q2 20231.6%
JAZZ PHARMACEUTICALS PLC32Q3 20231.6%
VERACYTE INC31Q2 20230.8%
LENNAR CORP30Q1 20222.7%

View CLOUGH CAPITAL PARTNERS L P's complete holdings history.

Latest significant ownerships (13-D/G)
CLOUGH CAPITAL PARTNERS L P Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Checkmate Pharmaceuticals, Inc.February 14, 20221,137,7645.3%
Correvio Pharma Corp.Sold outFebruary 24, 202000.0%
Cardiome Pharma CorpApril 27, 20182,058,7635.9%
CARVANA CO.April 27, 20181,072,0503.6%
HEALTHWAYS, INCJanuary 12, 20161,850,2895.1%
Kura Oncology, Inc.January 12, 20161,076,3335.0%
VERACYTE, INC.January 12, 20161,049,0543.8%
Solar Senior Capital Ltd.February 11, 2013325,0932.8%
MAGAL SECURITY SYSTEMS LTDSold outMarch 23, 201100.0%
BIOSPHERE MEDICAL INCSold outFebruary 10, 201100.0%

View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-16
13F-HR2022-05-16
13F-HR2022-02-14

View CLOUGH CAPITAL PARTNERS L P's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (3022578000.0 != 3022573000.0)

Export CLOUGH CAPITAL PARTNERS L P's holdings